Targeted Benzodiazepine Screen, Random, Urine

Use

Benzodiazepines are used to treat a range of disorders, from anxiety to seizures, and pain management. They carry a high risk for abuse and diversion, necessitating compliance monitoring through urine drug tests. Traditional benzodiazepine immunoassays often lack cross-reactivity with all benzodiazepines, which can result in negative screens for patients taking clonazepam or lorazepam despite compliance. This targeted screen offers a more sensitive and specific test to detect compliance with common benzodiazepines by identifying both the parent drug and its metabolites in urine.